1
Dec
2016
Cariprazine (Vraylar®)
Posted On December 1, 2016
By Dr.Adel Serag
And has No Comment
Cariprazine (Vraylar®) is a second-generation (atypical) antipsychotic. Here is basic information about this medication.
FDA-approved indications
1. Schizophrenia
2. Acute treatment of manic or mixed episodes associated with bipolar I disorder.
Dosage
Schizophrenia
Starting: 1.5 mg/day
Recommended: 1.5–6 mg/day
Bipolar Mania
Starting: 1.5 mg/day
Recommended: 3–6 mg/day
Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.
Dosage forms and strengths
Capsules: 1.5 mg, 3 mg, 4.5 mg, and 6 mg